NCAPD3 and non-small cell lung carcinoma: Our results were in agreement with our observations in NSCLC specimens, indicating the expression of NCAPD3 was significant upregulated in lung cancer cell lines, especially in the A549 and SPCA-1 (Fig. 2a, b).